Assembly Biosciences, Inc.(ASMB US)
$19.84-0.442.17%Ext:$19.04-0.804.05%(Market Closed · 23:47:22 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 19.8 | 38.3 | 58.5 | 31.1 | |||||||||||||||||
| Short Term Investments | 110.4 | 73.7 | 189.7 | 195.5 | |||||||||||||||||
| Cash and Short Term Investments | 130.2 | 112.1 | 248.1 | 226.6 | |||||||||||||||||
| Net Receivables | 0.0 | 0.4 | 1.0 | 0.5 | |||||||||||||||||
| Inventory | -3.2 | - | - | - | |||||||||||||||||
| Other Current Assets | 3.5 | 3.0 | 5.5 | 5.6 | |||||||||||||||||
| Total Current Assets | 133.8 | 115.5 | 254.5 | 232.6 | |||||||||||||||||
| Property, Plant & Equipment | 2.7 | 3.4 | 2.7 | 2.6 | |||||||||||||||||
| Long Term Investments | - | - | - | - | |||||||||||||||||
| Other Non-Current Assets | 0.3 | 0.3 | 0.3 | 0.3 | |||||||||||||||||
| Total Non-Current Assets | 3.0 | 3.7 | 3.0 | 2.9 | |||||||||||||||||
| Total Assets | 136.8 | 119.2 | 257.6 | 235.5 | |||||||||||||||||
| Account Payables | 0.5 | 0.6 | 1.2 | 1.1 | |||||||||||||||||
| Short Term Debt | - | - | - | - | |||||||||||||||||
| Deferred Revenue | 30.9 | 37.6 | 36.9 | 29.1 | |||||||||||||||||
| Other Current Liabilities | 1.1 | 9.1 | 7.5 | 2.4 | |||||||||||||||||
| Total Current Liabilities | 39.2 | 47.8 | 48.8 | 35.0 | |||||||||||||||||
| Long Term Debt | - | - | - | 1.9 | |||||||||||||||||
| Other Non-Current Liabilities | - | 35.4 | - | - | |||||||||||||||||
| Total Non-Current Liabilities | 56.5 | 38.0 | 2.1 | 1.9 | |||||||||||||||||
| Total Liabilities | 95.7 | 85.8 | 50.8 | 36.9 | |||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | |||||||||||||||||
| Retained Earnings | -785.7 | -825.9 | -832.0 | -841.1 | |||||||||||||||||
| Total Stockholders Equity | 41.1 | 33.4 | 206.8 | 198.6 | |||||||||||||||||
| Total Liabilities and Equity | 136.8 | 119.2 | 257.6 | 235.5 | |||||||||||||||||